Clinical Trial Detail

NCT ID NCT02703571
Title Study of Safety and Efficacy of Ribociclib and Trametinib in Patients With Metastatic or Advanced Solid Tumors
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications

colorectal cancer

pancreatic adenocarcinoma

Advanced Solid Tumor

Therapies

Ribociclib + Trametinib

Age Groups: adult senior

No variant requirements are available.